ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,970, issued on May 13, was assigned to UNIVERSITY OF KANSAS (Lawrence, Kan.) and HYLAPHARM LLC (Lawrence, Kan.).

"Imidazoquinoline compounds and prodrugs thereof" was invented by Laird Forrest (Lawrence, Kan.), Daniel Aires (Mission Hills, Kan.), Ryan Moulder (Lawrence, Kan.), Ruolin Lu (Lawrence, Kan.), Jordan Hunt (Lawrence, Kan.), Peter Kleindl (Lawrence, Kan.), Ti Zhang (Lawrence, Kan.), Chad Groer (Lawrence, Kan.) and Shuang Cai (Lawrence, Kan.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using the same for the treatment of cancers and as vacci...